You are viewing an old version of this page. View the current version.

Compare with Current View Page History

Version 1 Next »

Unless otherwise prescribed or justified and authorised, organic impurities in active substances are to be reported, identified wherever possible, and qualified as indicated in general monograph 2034,Substances for pharmaceutical use (Table 2034.-1 or Table 2034.-2).

Generally, specified impurities have their own specific acceptance criterion in the monograph. For other impurities, the decision tree in general chapter 5.10, Control of impurities in substances for pharmaceutical use may be used to determine the applicable acceptance criterion.

  • No labels